Cable Hill Partners LLC cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,222 shares of the healthcare conglomerate’s stock after selling 75 shares during the period. Cable Hill Partners LLC’s holdings in UnitedHealth Group were worth $429,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently made changes to their positions in UNH. Alliancebernstein L.P. grew its position in shares of UnitedHealth Group by 5.2% during the 4th quarter. Alliancebernstein L.P. now owns 11,485,225 shares of the healthcare conglomerate’s stock valued at $4,027,639,000 after acquiring an additional 569,142 shares during the period. Findlay Park Partners LLP grew its position in shares of UnitedHealth Group by 69.0% during the 3rd quarter. Findlay Park Partners LLP now owns 1,225,000 shares of the healthcare conglomerate’s stock valued at $381,918,000 after acquiring an additional 500,000 shares during the period. First Trust Advisors LP grew its position in shares of UnitedHealth Group by 402.0% during the 4th quarter. First Trust Advisors LP now owns 521,127 shares of the healthcare conglomerate’s stock valued at $182,749,000 after acquiring an additional 417,327 shares during the period. Morgan Stanley grew its position in shares of UnitedHealth Group by 4.9% during the 3rd quarter. Morgan Stanley now owns 7,003,292 shares of the healthcare conglomerate’s stock valued at $2,183,416,000 after acquiring an additional 325,936 shares during the period. Finally, CIBC Private Wealth Group LLC grew its position in shares of UnitedHealth Group by 25.5% during the 3rd quarter. CIBC Private Wealth Group LLC now owns 1,579,134 shares of the healthcare conglomerate’s stock valued at $492,232,000 after acquiring an additional 321,008 shares during the period. Institutional investors and hedge funds own 86.03% of the company’s stock.
Shares of NYSE UNH traded up $5.62 during mid-day trading on Tuesday, hitting $333.26. 50,607 shares of the company’s stock traded hands, compared to its average volume of 3,453,442. The company’s 50-day moving average is $341.25 and its two-hundred day moving average is $330.10. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.82 and a quick ratio of 0.82. The company has a market capitalization of $316.20 billion, a P/E ratio of 18.82, a PEG ratio of 1.55 and a beta of 0.74. UnitedHealth Group Incorporated has a 1 year low of $187.72 and a 1 year high of $367.95.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, January 19th. The healthcare conglomerate reported $2.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.39 by $0.13. The firm had revenue of $65.47 billion for the quarter, compared to analysts’ expectations of $64.98 billion. UnitedHealth Group had a net margin of 6.62% and a return on equity of 27.53%. The business’s revenue was up 7.5% compared to the same quarter last year. During the same period in the prior year, the company earned $3.90 EPS. Equities analysts anticipate that UnitedHealth Group Incorporated will post 16.75 EPS for the current fiscal year.
In related news, EVP Marianne D. Short sold 9,681 shares of the stock in a transaction dated Tuesday, December 29th. The shares were sold at an average price of $348.00, for a total value of $3,368,988.00. Following the sale, the executive vice president now directly owns 167,202 shares of the company’s stock, valued at approximately $58,186,296. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Richard T. Burke sold 7,000 shares of the stock in a transaction dated Tuesday, December 8th. The stock was sold at an average price of $349.78, for a total transaction of $2,448,460.00. Following the completion of the sale, the director now directly owns 159,487 shares in the company, valued at $55,785,362.86. The disclosure for this sale can be found here. Insiders have sold a total of 37,293 shares of company stock worth $12,886,401 over the last 90 days. Corporate insiders own 0.80% of the company’s stock.
A number of equities research analysts have recently issued reports on UNH shares. Piper Sandler boosted their price objective on shares of UnitedHealth Group from $385.00 to $409.00 and gave the company an “overweight” rating in a research report on Wednesday, November 11th. Mizuho boosted their price objective on shares of UnitedHealth Group from $361.00 to $380.00 and gave the company a “buy” rating in a research report on Monday, November 9th. Credit Suisse Group upped their target price on shares of UnitedHealth Group from $355.00 to $395.00 and gave the stock an “average” rating in a report on Thursday, November 5th. Deutsche Bank Aktiengesellschaft upped their target price on shares of UnitedHealth Group from $404.00 to $409.00 and gave the stock a “buy” rating in a report on Thursday, January 21st. Finally, Bank of America reaffirmed a “buy” rating and issued a $415.00 target price on shares of UnitedHealth Group in a report on Thursday, January 21st. Five research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $387.82.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery.
Recommended Story: Total Return
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.